Top-Rated StocksTop-RatedNYSE:EVH Evolent Health (EVH) Stock Price, News & Analysis → 1970’s computer coder Issues Shocking AI Warning (From InvestorPlace) (Ad) Free EVH Stock Alerts $26.97 -0.30 (-1.10%) (As of 05/9/2024 ET) Add Compare Share Share Today's Range$26.85▼$27.3650-Day Range$27.10▼$34.7452-Week Range$23.33▼$35.83Volume1.64 million shsAverage Volume951,209 shsMarket Capitalization$3.11 billionP/E RatioN/ADividend YieldN/APrice Target$42.70 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Evolent Health alerts: Email Address Evolent Health MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.92 Rating ScoreUpside/Downside58.4% Upside$42.70 Price TargetShort InterestBearish9.86% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.27Based on 5 Articles This WeekInsider TradingN/AProj. Earnings Growth58.62%From $0.87 to $1.38 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.83 out of 5 starsComputer And Technology Sector341st out of 593 stocksManagement Services Industry5th out of 5 stocks 4.5 Analyst's Opinion Consensus RatingEvolent Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.92, and is based on 11 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageEvolent Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Evolent Health's stock forecast and price target. Previous Next 0.0 Short Interest Percentage of Shares Shorted9.86% of the outstanding shares of Evolent Health have been sold short.Short Interest Ratio / Days to CoverEvolent Health has a short interest ratio ("days to cover") of 12.2, which indicates bearish sentiment.Change versus previous monthShort interest in Evolent Health has recently increased by 7.26%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldEvolent Health does not currently pay a dividend.Dividend GrowthEvolent Health does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for EVH. Previous Next 2.9 News and Social Media Coverage News SentimentEvolent Health has a news sentiment score of 1.27. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Evolent Health this week, compared to 3 articles on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Evolent Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.30% of the stock of Evolent Health is held by insiders.Read more about Evolent Health's insider trading history. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for Evolent Health are expected to grow by 58.62% in the coming year, from $0.87 to $1.38 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Evolent Health is -21.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Evolent Health is -21.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEvolent Health has a P/B Ratio of 2.87. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Evolent Health's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Gold Safe ExchangeTrump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.Protect your retirement savings from the inevitable devaluation of the dollar… About Evolent Health Stock (NYSE:EVH)Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.Read More EVH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart EVH Stock News HeadlinesMay 9, 2024 | prnewswire.comEvolent and Careology form strategic care navigation partnership to enhance cancer care in the U.S.May 9, 2024 | prnewswire.comEvolent Announces First Quarter 2024 ResultsMay 9, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.May 2, 2024 | americanbankingnews.comEvolent Health (EVH) to Release Earnings on ThursdayApril 23, 2024 | msn.comCitigroup Initiates Coverage of Evolent Health (EVH) with Buy RecommendationApril 18, 2024 | investing.comEvolent Health stock maintains price target with Overweight ratingApril 18, 2024 | prnewswire.comEvolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024April 15, 2024 | finance.yahoo.comEvolent Health, Inc. (EVH)May 9, 2024 | Banyan Hill Publishing (Ad)The Best AI Stock to Own in the World Today is Trading for Just $25“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.April 7, 2024 | finance.yahoo.comRecent 7.4% pullback isn't enough to hurt long-term Evolent Health (NYSE:EVH) shareholders, they're still up 134% over 5 yearsMarch 16, 2024 | finance.yahoo.comEVH Apr 2024 27.500 putMarch 15, 2024 | markets.businessinsider.comNavigating 4 Analyst Ratings For Evolent HealthMarch 1, 2024 | msn.comOppenheimer Initiates Coverage of Evolent Health (EVH) with Outperform RecommendationFebruary 27, 2024 | finance.yahoo.comWall Street Analysts Predict a 35.7% Upside in Evolent Health (EVH): Here's What You Should KnowFebruary 26, 2024 | finance.yahoo.comHere's What Analysts Are Forecasting For Evolent Health, Inc. (NYSE:EVH) After Its Annual ResultsFebruary 24, 2024 | finance.yahoo.comEvolent Health Full Year 2023 Earnings: EPS Misses ExpectationsFebruary 23, 2024 | markets.businessinsider.comThese Analysts Revise Their Forecasts On Evolent Health After Upbeat ResultsFebruary 23, 2024 | markets.businessinsider.comAnalyst Scoreboard: 4 Ratings For Evolent HealthFebruary 23, 2024 | finanznachrichten.deEvolent Health: Evolent Announces Fourth Quarter and Full Year 2023 ResultsFebruary 23, 2024 | markets.businessinsider.comBarclays Reaffirms Their Buy Rating on Evolent Health (EVH)February 23, 2024 | markets.businessinsider.comEvolent Health (EVH) Buy Rating Affirmed Amid Strong Q4 Results and Promising 2024 ProjectionsFebruary 23, 2024 | investing.comEvolent Health Inc (EVH)February 22, 2024 | benzinga.comEvolent Health Stock (NYSE:EVH) Insider TradesFebruary 22, 2024 | finance.yahoo.comEvolent Health Inc (EVH) Reports Robust Revenue Growth and Improved Adjusted EBITDA in 2023February 22, 2024 | prnewswire.comEvolent Announces Fourth Quarter and Full Year 2023 ResultsFebruary 22, 2024 | benzinga.comEvolent Health Stock (NYSE:EVH) Dividends: History, Yield and DatesFebruary 20, 2024 | msn.comTeladoc Health slides ~16% after hours as 2024 guidance, long-term outlook disappointsSee More Headlines Receive EVH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/22/2024Today5/09/2024Next Earnings (Confirmed)5/09/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorComputer and Technology Industry Management services Sub-IndustryN/A Current SymbolNYSE:EVH CUSIPN/A CIK1628908 Webwww.evolenthealth.com Phone(571) 389-6000Fax571-389-6001Employees4,700Year FoundedN/APrice Target and Rating Average Stock Price Target$42.70 High Stock Price Target$52.00 Low Stock Price Target$34.00 Potential Upside/Downside+58.3%Consensus RatingModerate Buy Rating Score (0-4)2.92 Research Coverage12 Analysts Profitability EPS (Most Recent Fiscal Year)($1.27) Trailing P/E RatioN/A Forward P/E Ratio31.00 P/E GrowthN/ANet Income$-113,040,000.00 Net Margins-5.76% Pretax Margin-10.31% Return on Equity6.60% Return on Assets2.73% Debt Debt-to-Equity Ratio0.56 Current Ratio1.01 Quick Ratio1.01 Sales & Book Value Annual Sales$1.96 billion Price / Sales1.59 Cash Flow$1.78 per share Price / Cash Flow15.18 Book Value$9.38 per share Price / Book2.88Miscellaneous Outstanding Shares115,430,000Free Float111,621,000Market Cap$3.11 billion OptionableOptionable Beta1.57 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Seth Barrie Blackley (Age 45)Co-Founder, CEO & Director Comp: $2MMr. Dan McCarthy (Age 39)CEO of New Century Health & President Comp: $1.4MMr. John Paul Johnson (Age 40)Chief Financial Officer Comp: $1.13MMr. Aammaad Shams (Age 40)Chief Accounting Officer Comp: $341.78kMr. Robert CruzChief Technology OfficerMs. Jessica WhiteChief Information OfficerMr. Seth R. FrankVice President of Investor RelationsMs. Kali BeyahChief People & Brand OfficerDr. John Tam M.D.Chief Strategy OfficerMr. Scott PritchardPresident of Performance SuiteMore ExecutivesKey CompetitorsPaycor HCMNASDAQ:PYCRTeradataNYSE:TDCDigitalOceanNASDAQ:DOCNVishay IntertechnologyNYSE:VSHSmead Value CNASDAQ:SVFCXView All CompetitorsInsiders & InstitutionsScout Investments Inc.Bought 180,382 shares on 5/9/2024Ownership: 0.156%State Board of Administration of Florida Retirement SystemSold 5,260 shares on 5/9/2024Ownership: 0.023%Russell Investments Group Ltd.Sold 2,299 shares on 5/8/2024Ownership: 0.083%ProShare Advisors LLCBought 1,962 shares on 5/8/2024Ownership: 0.017%Headlands Technologies LLCBought 1,411 shares on 5/8/2024Ownership: 0.001%View All Insider TransactionsView All Institutional Transactions EVH Stock Analysis - Frequently Asked Questions Should I buy or sell Evolent Health stock right now? 12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last year. There are currently 1 hold rating and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" EVH shares. View EVH analyst ratings or view top-rated stocks. What is Evolent Health's stock price target for 2024? 12 equities research analysts have issued 1 year price objectives for Evolent Health's shares. Their EVH share price targets range from $34.00 to $52.00. On average, they expect the company's stock price to reach $42.70 in the next year. This suggests a possible upside of 58.4% from the stock's current price. View analysts price targets for EVH or view top-rated stocks among Wall Street analysts. How have EVH shares performed in 2024? Evolent Health's stock was trading at $33.03 at the start of the year. Since then, EVH shares have decreased by 18.4% and is now trading at $26.96. View the best growth stocks for 2024 here. Are investors shorting Evolent Health? Evolent Health saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 11,380,000 shares, an increase of 7.3% from the March 31st total of 10,610,000 shares. Based on an average daily volume of 934,800 shares, the short-interest ratio is currently 12.2 days. View Evolent Health's Short Interest. When is Evolent Health's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our EVH earnings forecast. How can I listen to Evolent Health's earnings call? Evolent Health will be holding an earnings conference call on Thursday, May 9th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link. How were Evolent Health's earnings last quarter? Evolent Health, Inc. (NYSE:EVH) posted its quarterly earnings data on Thursday, February, 22nd. The technology company reported $0.15 earnings per share for the quarter, topping analysts' consensus estimates of $0.02 by $0.13. The technology company earned $556.06 million during the quarter, compared to the consensus estimate of $541.87 million. Evolent Health had a negative net margin of 5.76% and a positive trailing twelve-month return on equity of 6.60%. What ETFs hold Evolent Health's stock? ETFs with the largest weight of Evolent Health (NYSE:EVH) stock in their portfolio include Fidelity Digital Health ETF (FDHT), Fidelity Disruptive Medicine ETF (FMED), Jpmorgan Healthcare Leaders ETF (JDOC), Harbor Small Cap Explorer ETF (QWST).iShares U.S. Healthcare Providers ETF (IHF) and What guidance has Evolent Health issued on next quarter's earnings? Evolent Health issued an update on its FY 2024 earnings guidance on Thursday, February, 22nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.4 billion-$2.5 billion, compared to the consensus revenue estimate of $2.3 billion. What is Seth Blackley's approval rating as Evolent Health's CEO? 12 employees have rated Evolent Health Chief Executive Officer Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among the company's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Evolent Health own? Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include Xtrackers California Municipal Bond ETF (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Advanced Micro Devices (AMD), Energy Transfer (ET), Chipotle Mexican Grill (CMG), Ford Motor (F), Cisco Systems (CSCO) and Heron Therapeutics (HRTX). When did Evolent Health IPO? Evolent Health (EVH) raised $150 million in an IPO on Friday, June 5th 2015. The company issued 10,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs acted as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers. Who are Evolent Health's major shareholders? Evolent Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include William Blair Investment Management LLC (3.22%), Zevenbergen Capital Investments LLC (0.49%), Hodges Capital Management Inc. (0.41%), Peregrine Capital Management LLC (0.26%), Swiss National Bank (0.18%) and Scout Investments Inc. (0.16%). Insiders that own company stock include Cheryl Scott, Daniel Joseph Mccarthy, Diane Holder, Frank J Williams, Frank J Williams, John Paul Johnson, Jonathan Weinberg, Mary Bridget Duffy, Seth Blackley, Simon Maisey and Steve Tutewohl. View institutional ownership trends. How do I buy shares of Evolent Health? Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:EVH) was last updated on 5/9/2024 by MarketBeat.com Staff From Our Partners1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeUrgent Nvidia WarningAltimetryThe Crypto 9-5 Escape PlanCrypto 101 Media348 million Americans lives to END as we know it?The Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolent Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.